Printer Friendly

Browse Lung diseases, Obstructive topic

Drug therapy subtopic

Articles

1-190 out of 190 article(s)
Title Author Type Date Words
Verona Pharma to present COPD drug data to leading conference. Conference news Aug 25, 2020 239
Verona Pharma kicks off second part of phase II trial assessing potential of COPD drug used in a pressurised metered-dose inhaler. Aug 20, 2020 260
AstraZeneca pays US$150mln milestone as COPD treatment Breztri Aerosphere gets US approval. Jul 25, 2020 280
Natural Products: Optimizing Cancer Treatment through Modulation of Redox Balance. Rijo, Patricia; Pesic, Milica; Fernandes, Ana S.; Santos, Claudia N. Jun 30, 2020 1586
Mechanism of YuPingFeng in the Treatment of COPD Based on Network Pharmacology. Yin, Yunhong; Liu, Jianyu; Zhang, Mengyu; Li, Rui; Liu, Xiao; Yang, Yican; Qu, Yi- Qing Jun 30, 2020 6313
Verona Pharma rallies 5% after conference accepts abstracts for COPD drug. Conference news May 4, 2020 219
Synairgen to start COVID-19 trial of lead drug imminently. Mar 19, 2020 342
Verona Pharma's COPD drug 'has potential to significantly benefit patients' - Kathy Rickard. Feb 29, 2020 155
Verona Pharma chief excited by COPD drug's potential. Nov 6, 2019 439
Circassia Pharmaceuticals Launches COPD Treatment Duaklir In US. Oct 21, 2019 180
Theravance, Mylan study highlights possible role of Yupelri in COPD treatment. May 20, 2019 252
US Food and Drug Administration Approves Duaklir Pressair for Patients with Chronic Obstructive Pulmonary Disease. Apr 22, 2019 465
FDA Approves Tudorza Pressair (aclidinium bromide inhalation powder) Supplemental New Drug Application to include data for the Reduction of COPD Exacerbations and Hospitalizations. Apr 3, 2019 453
Two-thirds of COPD patients not using inhalers correctly. Haelle, Tara Nov 1, 2018 748
AstraZenca receives positive opinion from CHMP for Bevespi Aerosphere for the treatment of COPD. Oct 22, 2018 233
AstraZenca receives positive opinion from CHMP for Bevespi Aerosphere for the treatment of COPD. Oct 22, 2018 232
Interpreting Recent Developments in COPD Treatments. Sethi, Sanjay; Dransfield, Mark T. Report Oct 1, 2018 5664
Small Reduction in Lung Function With Tx De-Escalation in COPD; No difference in exacerbations with indacaterol/glycopyrronium for non-frequently exacerbating COPD. Sep 14, 2018 277
Classical and Emerging Therapies against Chronic Obstructive Pulmonary Disease. Feng, Han-Rong; Zhang, Chao; Ying, Song-Min Report Aug 20, 2018 2529
Procalcitonin-Guided Antibiotic Treatment in Lower Respiratory Tract Infections/Prokalsitonin Rehberliginde Alt Solunum Yolu Enfeksiyonlari Antibiyotik Tedavisi. Balci, Merih Kalamanoglu; Balcan, Baran; Yildizeli, Sehnaz Olgun; Ceyhan, Berrin Aug 1, 2018 4311
Verona Pharma's ATS 2018 highlights RPL554 as COPD treatment. May 21, 2018 173
Theravance Biopharma wins US FDA's expanded indication for once-daily Trelegy Ellipta therapy for treating COPD patients. Apr 26, 2018 266
Theravance Biopharma wins US FDA's expanded indication for once-daily Trelegy Ellipta therapy for treating COPD patients. Apr 26, 2018 262
Glaxo, Innoviva report FDA approves expanded indication for Trelegy Ellipta. Apr 24, 2018 112
Considerations for Optimal Inhaler Device Selection in Chronic Obstructive Pulmonary Disease. Dhand, Rajiv; Cavanaugh, Tricia; Skolnik, Neil Clinical report Feb 1, 2018 6045
Risk of Cardiovascular Events Associated with Inhaled Corticosteroid Treatment in Patients with Chronic Obstructive Pulmonary Disease: A Meta-Analysis. Jing, Xia; Li, Yufeng; Xu, Jianying Jan 1, 2018 8494
Comparative Efficacy of Chinese Herbal Injections for Treating Acute Exacerbation of Chronic Obstructive Pulmonary Disease: A Bayesian Network Meta-Analysis of Randomized Controlled Trials. Duan, Xiaojiao; Wu, Jiarui; Huang, Xingyue; Wang, Kaihuan; Zhao, Yi; Zhang, Dan; Liu, Xinkui; Zhang, Jan 1, 2018 6251
EMA grants marketing authorisation to GSK and Innovia for Trelegy Ellipta inhaler. Nov 16, 2017 238
EMA grants marketing authorisation to GSK and Innovia for Trelegy Ellipta inhaler. Nov 16, 2017 234
Theravance Biopharma wins US FDA approval for Trelegy Ellipta (Closed Triple) to treat appropriate patients with COPD. Sep 20, 2017 255
CHIESI FARMACEUTICI - TRIMBOW[R] IS THE FIRST TRIPLE COMBINATION IN A SINGLE INHALER FOR THE TREATMENT OF COPD TO RECEIVE POSITIVE OPINION FROM THE CHMP IN EUROPE -- 22/5/2017. Clinical report Jun 1, 2017 644
CHIESI FARMACEUTICI - TRIMBOW[R] IS THE FIRST TRIPLE COMBINATION IN A SINGLE INHALER FOR THE TREATMENT OF COPD TO RECEIVE POSITIVE OPINION FROM THE CHMP IN EUROPE -- 22/5/2017. Clinical report May 26, 2017 643
Usefulness of antibiotics in acute exacerbations of COPD. Nair, Sandhya Sivasankaran; Nair, Reshmi Sasidharan; Rasheed, Fathahudeen Abdul Report Apr 24, 2017 2108
Glenmark gets go-ahead from US FDA to start phase II clinical trials for respiratory drug. Mar 8, 2017 264
Glenmark gets go-ahead from US FDA to start phase II clinical trials for respiratory drug. Mar 8, 2017 260
Gold: Base COPD treatment on symptoms, exacerbation. Otto, M. Alexander Report Feb 1, 2017 574
Impaired Hemorheology in Exacerbations of COPD. Ugurlu, Erhan; Kilic-Toprak, Emine; Can, Ilknur; Kilic-Erkek, Ozgen; Altinisik, Goksel; Bor-Kucukata Report Jan 1, 2017 6952
GlaxoSmithKline steps up filing for promising COPD treatment. Dec 12, 2016 435
GlaxoSmithKline and Innoviva win MHLW approval in Japan for Relvar Ellipta 100/25 mcg for the treatment of COPD. Dec 5, 2016 274
GlaxoSmithKline and Innoviva win MHLW approval in Japan for Relvar Ellipta 100/25 mcg for the treatment of COPD. Dec 5, 2016 270
Effects of bisoprolol in combination with trimetazidine on the treatment of heart failure and concomitant chronic obstructive pulmonary disease. Oct 31, 2016 2933
Case Studies on Drug Development and Novel Targets from Glenmark Pharmaceuticals and Novartis at COPD 2016. Jul 16, 2016 460
Market Report, "COPD Drugs Market in China 2016-2020", published. Jul 3, 2016 486
Glycopyrrolate/formoterol combo gets nod for COPD. Lennon, Katie Wagner May 15, 2016 171
AstraZeneca passes US FDA approval for BEVESPI AEROSPHERE inhalation aerosol for treating chronic obstructive pulmonary disease (COPD). Apr 26, 2016 206
AstraZeneca passes US FDA approval for BEVESPI AEROSPHERE inhalation aerosol for treating chronic obstructive pulmonary disease (COPD). Apr 26, 2016 202
Smoking, viral infection reduce efficacy of lung medications. Apr 12, 2016 243
Novartis and Qualcomm collaborate on digital innovation with the Breezhaler COPD treatment. Jan 6, 2016 255
Novartis and Qualcomm collaborate on digital innovation with the Breezhaler COPD treatment. Jan 6, 2016 251
COPD optimizing treatment. Ahmed-Sarwar, Nabila; Pierce, Deirdre P.; Holub, David C. Cover story Oct 1, 2015 4694
Glaxo and Theravance to file COPD drug in Japan. Sep 25, 2015 207
Glaxo and Theravance to file COPD drug in Japan. Sep 25, 2015 203
Stiolto Respimat OK'd for treatment of COPD. Jul 6, 2015 117
Pulmatrix partners with Mylan for ex-US development of PUR0200 for the treatment of COPD. Jun 17, 2015 212
Pulmatrix partners with Mylan for ex-US development of PUR0200 for the treatment of COPD. Jun 17, 2015 208
Combinations of long acting [[beta].sub.2] agonists to tiotropium: a randomized, double-blind, placebo-controlled, active-drug controlled, parallel design academic clinical trial in moderate COPD male patients. Imran, Mohammed; Chhabra, Sunil Kumar; Kotwani, Anita Report Apr 1, 2015 3269
New effective treatment for COPD patients. Mar 14, 2015 978
ANTIBIOTICS TARGET COPD TREATMENT. Dec 1, 2014 130
This deadly lung problem is often misdiagnosed-and can kill you ; Many doctors don't recognize the symptoms of chronic obstructive pulmonary disease (COPD). A new drug can help reduce the risks. Oct 14, 2014 1059
New treatment for COPD available in PH. Oct 4, 2014 655
European marketing authorisation granted for Anoro (umeclidinium/vilanterol) for the treatment of COPD. May 9, 2014 246
European marketing authorisation granted for Anoro (umeclidinium/vilanterol) for the treatment of COPD. May 9, 2014 242
Q: What are the benefits and risks of inhaled corticosteroids for COPD? Hamilton, Tanya; Miller, John B.; Vincent, E. Chris; St. Anna, Leilani May 1, 2014 1436
GSK wins US FDA's approval for Incruse Ellipta (62.5 mcg) for the treatment of COPD. May 1, 2014 190
GSK wins US FDA's approval for Incruse Ellipta (62.5 mcg) for the treatment of COPD. May 1, 2014 186
GlaxoSmithKline & Theravance partnership unveils Anoro Ellipta in the US for the treatment of COPD. Apr 29, 2014 181
GlaxoSmithKline & Theravance partnership unveils Anoro Ellipta in the US for the treatment of COPD. Apr 29, 2014 177
Theravance announces initiation of phase 2b study of an investigational LAMA for the treatment of COPD. Apr 14, 2014 224
Theravance announces initiation of phase 2b study of an investigational LAMA for the treatment of COPD. Apr 14, 2014 220
Clinical efficacy of nebulized budesonide in acute exacerbation of COPD. Nemagouda, S. Report Apr 14, 2014 5255
Steroids for acute COPD--but for how long? Not only was a shorter course of glucocorticoid therapy as effective as a 14-day regimen, but there was no difference in the time to next exacerbation. Asher, Gary N.; Stevermer, James J. Clinical report Jan 1, 2014 1326
GlaxoSmithKline plc & Theravance Inc partnership wins US FDA's approval for ANORO ELLIPTA for the treatment of COPD. Dec 19, 2013 250
GlaxoSmithKline plc & Theravance Inc partnership wins US FDA's approval for ANORO ELLIPTA for the treatment of COPD. Dec 19, 2013 246
GSKa[euro](tm)s and Theravancea[euro](tm)s BREO ELLIPTA now available in US pharmacies for the treatment of COPD. Oct 31, 2013 139
GSKa[euro](tm)s and Theravancea[euro](tm)s BREO ELLIPTA now available in US pharmacies for the treatment of COPD. Oct 31, 2013 125
GlaxoSmithKline plc wins FDA Advisory Committee's support of Umeclidinium/Vilanterol's approval for COPD in the US. Sep 11, 2013 230
GlaxoSmithKline plc wins FDA Advisory Committee's support of Umeclidinium/Vilanterol's approval for COPD in the US. Sep 11, 2013 226
COPD may boost risk of cerebral microbleeds. Nogrady, Bianca Clinical report Aug 1, 2013 412
PAKISTAN AT HIGH RISK MYTHS ABOUT COPD HAMPERING EARLY TREATMENT. Jul 21, 2013 862
Once-daily COPD drug approved by FDA. Jul 1, 2013 158
Shorter steroid treatment eased COPD exacerbations. Moon, Mary Ann Jun 1, 2013 502
Rigorous study supports 5-day regimen. Sin; Park Brief article Jun 1, 2013 135
Advisory panel backs ICS/LABA inhaler for COPD. Mechcatie, Elizabeth May 1, 2013 915
GlaxoSmithKline plc gets FDA Advisory Committee's recommendation to approve BREO ELLIPTA for COPD. Apr 18, 2013 218
GlaxoSmithKline plc gets FDA Advisory Committee's recommendation to approve BREO ELLIPTA for COPD. Apr 18, 2013 214
Macrolide resistance: cause for concern? Hahn, David L. Letter to the editor Sep 1, 2012 376
Q/Do antibiotics improve outcomes for patients hospitalized with COPD exacerbations? Mathew, Sagi; Zeitlin, Deborah; Rickett, Katherine Sep 1, 2012 669
Twice-daily inhaler for COPD. Aug 1, 2012 242
Forest Laboratories Inc and Almirall SA receives FDA approval of Tudorza Pressair for long term COPD. Jul 24, 2012 185
Consider adding this drug to fight COPD that's severe: daily use of azithromycin, in conjunction with the usual COPD regimen, has been found to reduce acute exacerbations in patients with moderate to severe disease. Hobbs, Keia; Brown, Dionna Jul 1, 2012 1457
Panel backs inhaled anticholinergic for COPD. Mechcatie, Elizabeth Mar 15, 2012 677
R&D projects take on challenge of improving COPD treatment. Feb 27, 2012 343
Forest Laboratories Inc receives positive FDA Advisory Committee's recommendation for approval of Aclidinium Bromide for COPD. Feb 24, 2012 193
Would this long-acting bronchodilator be better for your patient? Tiotropium outperformed salmeterol in reducing the frequency of exacerbations in patients with moderate-to-severe COPD. Gwynne, Mark; Mounsey, Anne Clinical report Feb 1, 2012 1611
Broccoli compound could help beat drug resistance in COPD. Oct 18, 2011 171
Moxifloxacin appears noninferior in COPD exacerbation Tx. London, Susan Clinical report Oct 15, 2011 536
FDA greenlights Boehringer Ingelheim's Combivent Respimat for COPD treatment. Oct 10, 2011 147
Almirall introduces COPD medicine in Spain. Oct 4, 2011 147
NICE seeks additional data for severe COPD medicine Daxas. Sep 12, 2011 185
Azithromycin prevented COPD exacerbations. Moon, Mary Ann Report Sep 1, 2011 795
A kinder side of red tides? Holzman, David C. Report Aug 1, 2011 1053
Forest, Almirall seek FDA nod for aclidinium bromide for COPD treatment. Jun 30, 2011 133
Inhaled anticholinergics linked to urinary risks: men taking the drugs for COPD, especially those with BPH, were at risk for acute urinary retention. Moon, Mary Ann Jun 15, 2011 736
COPD patients using mist inhaler at higher death risk. Jun 15, 2011 226
Daily azithromycin cut COPD exacerbations. Tucker, Miriam E. Jun 1, 2011 1055
FDA detours COPD drug on road to approval. Mechcatie, Elizabeth May 1, 2011 885
COPD drug gets approved. Mar 15, 2011 435
FDA advisory committee recommends approval of Novartis QAB149 for COPD. Mar 9, 2011 211
Forest receives FDA approval of Daliresp (Roflumilast) as a treatment to reduce the risk of COPD exacerbations. Mar 1, 2011 188
Guideline for the management of chronic obstructive pulmonary disease-2011 update. Abdool-Gaffar, M.S.; Ambaram, A.; Ainslie, G.M.; Bolliger, C.T.; Feldman, C.; Geffen, L.; Irusen, E. Report Jan 1, 2011 9996
Vinpocetine shows promise for chronic inflammation. Dye, Dayna Brief article Aug 1, 2010 173
Roflumilast rejected for COPD. Apr 15, 2010 184
How to keep COPD under check. Report Apr 15, 2010 317
COPD-related hospitalization rate lower with tiotropium than other regimens. Jancin, Bruce Report Apr 15, 2010 453
COPD hospitalization rate low for tiotropium. Jancin, Bruce Feb 15, 2010 512
COPD inhaler deemed safe. Feb 15, 2010 183
Panel backs new tiotropium claim. Brief article Jan 1, 2010 138
Leading figures from the real estate and construction industries joined over 1000 guests to raise over $2.04 million at the annual Winter's Eve black-tie dinner to benefit National Jewish Health and to establish The Jonathan L. and Wendy S. Mechanic Fund for Lung Cancer and COPD Research and Treatment Programs. Dec 23, 2009 129
Once-daily indacaterol promising for COPD. Jancin, Bruce Dec 1, 2009 554
Tiotropium backed for COPD exacerbation. Mechcatie, Elizabeth Dec 1, 2009 485
Roflumilast shows promise for COPD. Jancin, Bruce Dec 1, 2009 329
Finnish Biotie begins trial of inhibitor for COPD treatment. Sep 15, 2009 136
Osiris Therapeutics Inc. Brief article Jun 29, 2009 219
News and views. Kessinger, Jack Report Jun 1, 2009 646
FDA approves Symbicort for COPD treatment. Mechcatie, Elizabeth Apr 1, 2009 283
Combination approved for treatment of COPD. Mechcatie, Elizabeth Apr 1, 2009 275
COPD is a highly preventable and treatable disease, the latter often being forgotten. Abdool-Gaffar, Sabeer Report Apr 1, 2009 1583
Budesonide inhalation suspension in adults with poorly controlled asthma or chronic obstructive pulmonary disease. Marcus, Philip Report Mar 1, 2009 4826
Hope and concerns arise from COPD research: Cleveland Clinic expert says it's too early to draw conclusions from recent studies of drugs for this common lung disease. Jan 1, 2009 597
Safety data mixed on anticholinergics for COPD. Zoler, Mitchel L. Dec 15, 2008 1070
Tiotropium for COPD. Ebbert, Jon O.; Tangalos, Eric G. Case study Dec 15, 2008 902
Assessing treatment effects of inhaled corticosteroids on medical expenses and exacerbations among COPD patients: longitudinal analysis of managed care claims. Akazawa, Manabu; Stearns, Sally C.; Biddle, Andrea K. Dec 1, 2008 7200
Do inhaled anticholinergics for COPD increase the risk of cardiovascular disease? Clinical report Dec 1, 2008 439
COPD drugs associated with heart attack and stroke. Dec 1, 2008 149
Drug therapy first ever to decrease loss of lung function in COPD. Nov 1, 2008 782
Is a short course of antibiotics effective for acute exacerbation of chronic bronchitis? Clinical report Nov 1, 2008 327
Tiotropium didn't curb lung function decline in COPD. Wendling, Patrice Oct 15, 2008 726
Tiotropium's [FEV.sub.1] benefit in COPD scrutinized. Wendling, Patrice Oct 15, 2008 679
The use of cardioselective beta-blockers can improve survival in "carefully selected" patients with chronic obstructive pulmonary disease (COPD) undergoing vascular surgery, according to a report in the first October issue of the American Journal of Respiratory and Critical Care Medicine. Brief article Oct 13, 2008 248
Steroids might stem resistance to [[beta].sub.2] agonists. Lowry, Fran Brief article Oct 1, 2008 218
Combination treatment improved control in COPD. Walsh, Nancy Oct 1, 2008 448
Combination treatment bolsters COPD control. Walsh, Nancy Jul 1, 2008 341
Oral or IV steroids for inpatient COPD? Brief article Jun 1, 2008 296
Advair use extended to cut COPD exacerbations. Osborne, Randall Brief article Jun 1, 2008 238
Antibiotics cut treatment failure in acute COPD. Tucker, Miriam E. May 15, 2008 918
New guideline for COPD: inhaled treatments similarly effective. Jan 1, 2008 451
One in three use inhalers incorrectly. Wendling, Patrice Nov 15, 2007 823
COPD, comorbid pneumonia present diagnostic and treatment challenges. Johnson, Kate Jun 1, 2007 206
Appropriate antibiotic important in COPD with pneumonia. Jun 1, 2007 314
Survival in chronic obstructive airways disease. Brief article May 1, 2007 281
COPD: data reassure on long-acting [beta]-agonists. Jancin, Bruce Feb 1, 2007 464
Spirometry is underused for diagnosis and staging of COPD. Wendling, Patrice Feb 1, 2007 462
The effect of extracts from ginger rhizome on inflammatory mediator production. Lantz, R.C.; Chen, G.J.; Sarihan, M.; Solyom, A.M.; Jolad, S.D.; Timmermann, B.N. Drug overview Feb 1, 2007 4391
When are antibiotics indicated for acute COPD exacerbations? Balser, Emily; Neher, Jon O.; Safranek, Sarah Clinical report Dec 1, 2006 953
COPD management misses the mark. Wendling, Patrice Disease/Disorder overview Dec 1, 2006 538
Statins may slow smokers lung ailments. Jancin, Bruce Clinical report Dec 1, 2006 363
Inhaled steroids cut death risk in COPD patients. Brief article Dec 1, 2006 133
Combo therapy cuts mortality in COPD patients. Jancin, Bruce Nov 15, 2006 649
Combo therapy reduces mortality in COPD patients: landmark trial brings 'message of hope.'. Jancin, Bruce Clinical report Nov 15, 2006 582
Corticosteroids benefit patients with moderate to severe COPD. Sep 1, 2006 370
Drug improves sleep induction without sedation. Jancin, Bruce Nov 1, 2005 581
Pfizer drops pipeline projects. Brief Article Aug 1, 2005 140
Inhalants mistakenly swallowed due to faulty drug labeling. Wachter, Kerri Jun 15, 2005 290
Chronic obstructive pulmonary disease. Mechcatie, Elizabeth; Sullivan, Michele G. May 1, 2005 1262
Do beta-blockers worsen respiratory status for patients with COPD? Baselli, Lynda M.; Oswald, Mark A.; Nashelsky, Joan M. May 1, 2005 816
Atrovent HFA Inhalation Aerosol, Evoclin Foam. McNamara, Damian Jan 1, 2005 620
Treating acute bacterial exacerbation of chronic bronchitis: how can therapy be optimized? Dec 1, 2004 959
Advair Diskus bests Combivent for COPD. Aug 1, 2004 301
Advair beats combivent for patients with COPD. Jul 1, 2004 321
Are beta-2-agonists or anticholinergics more effective for treating COPD? Richmond, John R.; Babcock, Chad F.; Mayo, Helen G.; Hoekzema, Grant Jun 1, 2004 1293
Oral COPD treatment fails to obtain panel's support: longer studies needed. Mechcatie, Elizabeth Oct 15, 2003 513
Oral COPD treatment not backed for approval: longer studies needed. (chronic obstructive pulmonary disease, cilomilast). Mechcatie, Elizabeth Oct 15, 2003 552
Oral prednisone prevents relapse in COPD exacerbations. Courtney, A. Ursulla Oct 1, 2003 413
Inhaled steroids for COPD improve symptoms, survival. (Still a Controversial Practice). Kirn, Timothy F. Mar 1, 2003 967
Levalbuterol no better than albuterol for COPD. (Combo Didn't Fare Well Either). Brief Article Mar 1, 2003 319
Inhaled steroids help improve COPD survival. (Improved Symptoms). Kirn, Timothy F. Jan 15, 2003 972
Levalbuterol does not top albuterol in treating COPD. (No Gain from Adding Ipratroplum). Kirn, Timothy F. Brief Article Jan 1, 2003 304
FDA approval likely for once-daily COPD drug. (Dyspnea Claim Rejected). Mechcatie, Elizabeth Oct 15, 2002 568
Panel backs once-daily anticholinergic for COPD. (Dyspnea Claim Rejected). Mechcatie, Elizabeth Oct 15, 2002 710
Ofloxacin in COPD. (Clinical Capsules). Worcester, Sharon Brief Article Mar 1, 2002 206
Bupropion helps COPD Patients stop smoking. (Less Craving and Anxiety). Finn, Robert Dec 1, 2001 253
Foradil. (New & Approved). Mechcatie, Elizabeth Nov 15, 2001 166
PRO & CON: Should inhaled corticosteroids be used in COPD? (Opinion). Brief Article Nov 1, 2001 874
PRO & CON. Aug 15, 2001 1006
PRO & CON. Brief Article Mar 15, 2001 759
Are high-dose inhaled steroids effective for chronic obstructive pulmonary disease (COPD)? Rosenbaum, Dan; Merenstein, Dan; McCormally, Terence Sep 1, 2000 769
How Green Was My Sputum. Brief Article Aug 1, 2000 141
Inhaled Steroids May Help Elderly COPD Patients. ZOLER, MITCHEL L. Jul 1, 2000 323
EFFECT OF SYSTEMIC GLUCOCORTICOIDS ON EXACERBATIONS OF CHRONIC OBSTRUCTIVE PULMONARY DISEASE. Adelman, Alan Oct 1, 1999 783
Xopenex Inhalation Solution. Mechcatie, Elizabeth May 15, 1999 286

Terms of use | Privacy policy | Copyright © 2020 Farlex, Inc. | Feedback | For webmasters